Huntington National Bank lowered its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 22.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,783 shares of the semiconductor company’s stock after selling 5,203 shares during the quarter. Huntington National Bank’s holdings in Synopsys were worth $8,631,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Kieckhefer Group LLC acquired a new stake in Synopsys in the 4th quarter valued at approximately $27,000. Whipplewood Advisors LLC bought a new position in shares of Synopsys in the fourth quarter worth $33,000. Sierra Ocean LLC acquired a new position in shares of Synopsys during the fourth quarter valued at $39,000. Hazlett Burt & Watson Inc. raised its stake in shares of Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock valued at $44,000 after purchasing an additional 20 shares in the last quarter. Finally, Newbridge Financial Services Group Inc. acquired a new stake in Synopsys in the fourth quarter worth about $51,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Up 0.6 %
Shares of NASDAQ:SNPS opened at $438.55 on Thursday. The company has a market cap of $67.81 billion, a P/E ratio of 30.20, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. The company’s fifty day moving average is $479.67 and its two-hundred day moving average is $504.45. Synopsys, Inc. has a 12-month low of $422.65 and a 12-month high of $624.80.
Analysts Set New Price Targets
Read Our Latest Analysis on Synopsys
Insider Activity
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company’s stock, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the sale, the insider now directly owns 116,671 shares of the company’s stock, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,909 shares of company stock worth $22,794,835. 0.62% of the stock is owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Buy P&G Now, Before It Sets A New All-Time High
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- 3 Small Caps With Big Return Potential
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Profit From Growth Investing
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.